Abstract

Objectives:To evaluate health care professionals’ knowledge on warfarin interactions with drugs and herbs.Methods:A self-administered questionnaire was developed to assess health care professionals’ knowledge on warfarin interactions with drug and herb. Respondents were asked to classify 15 drugs that may effect on warfarin action as “enhance”, “inhibit “, “no effect”. The study sample involved health care professionals (physicians, pharmacists and nurses) from king Salman hospital, Saudi Arabia.Results:About 92.2% of health care professionals identified warfarin interactions with aspirin, 4.4% for warfarin and fluoxetine. Warfarin and cardiac agents (atenolol) was correctly identified by 11.1% of respondents. In warfarin –herb interactions section, the majority of respondents (66.7%) identified the interaction between green tea and warfarin. Approximately one-third of respondents (n=33) correctly classified warfarin interactions with cardamom. No significant difference was found between the health care professionals (p=0.49) for warfarin-drug interactions knowledge score and p= 0.52 for warfarin- herb interactions knowledge score.Conclusion:This study suggests that health care professionals’ knowledge of warfarin- drug-herb interactions was inadequate. Therefore, health care professionals should receive more education programs about drug-drug/herb interactions to provide appropriate patient counseling and optimal therapeutic outcomes.

Highlights

  • Warfarin is the most commonly used oral anticoagulant and has been used in preventing thromboembolic events in patients with chronic arterial fibrillation, prosthetic heart valves, venous thrombosis canonry hear disorders.[1,2,3] Mode of action of Warfarin believes to exert its effect by lowering the amount of active vitamin K available for the activation of clotting factors II, VII, IX, and X.4 Use of warfarin is still limited despite the strong evidence for its clinical value

  • Kruskal-Wallis test showed that there is no significant difference (p>0.05) between the three groups regarding their knowledge of warfarin drug-drug interactions

  • The result of the current study showed that the majority of the HCPs had poor knowledge on herb-warfarin interactions

Read more

Summary

Introduction

Warfarin is the most commonly used oral anticoagulant and has been used in preventing thromboembolic events in patients with chronic arterial fibrillation, prosthetic heart valves, venous thrombosis canonry hear disorders.[1,2,3] Mode of action of Warfarin believes to exert its effect by lowering the amount of active vitamin K available for the activation of clotting factors II, VII, IX, and X.4 Use of warfarin is still limited despite the strong evidence for its clinical value. Warfarin is the most commonly used oral anticoagulant and has been used in preventing thromboembolic events in patients with chronic arterial fibrillation, prosthetic heart valves, venous thrombosis canonry hear disorders.[1,2,3] Mode of action of Warfarin believes to exert its effect by lowering the amount of active vitamin K available for the activation of clotting factors II, VII, IX, and X.4. Use of warfarin is still limited despite the strong evidence for its clinical value. This may be due to the narrow therapeutic index, warfarin’ drug and herb interactions, and resulting in non-therapeutic anticoagulation or life-threatening hemorrhagic complications.[5,6,7].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.